Variables Associated with Short-Term Weight Loss in a Cohort of Patients with Morbid Obesity According to Age and Three Types of Bariatric Surgery

Maria D Alvarez-Bermudez, Flores Martin-Reyes, Luis Ocaña-Wilhelmi, Francisco J Moreno-Ruiz, Juan Alcaide Torres, Diego Fernandez-Garcia, Sergio Valdes, Noelia Moreno-Morales, Eduardo Garcia-Fuentes, Francisco J Tinahones, Lourdes Garrido-Sanchez, Maria D Alvarez-Bermudez, Flores Martin-Reyes, Luis Ocaña-Wilhelmi, Francisco J Moreno-Ruiz, Juan Alcaide Torres, Diego Fernandez-Garcia, Sergio Valdes, Noelia Moreno-Morales, Eduardo Garcia-Fuentes, Francisco J Tinahones, Lourdes Garrido-Sanchez

Abstract

Background The percentage of excess weight lost (%EWL) after bariatric surgery (BS) shows great discrepancies from one individual to another. Objective To evaluate the %EWL one year after BS and to determine the existence of baseline biomarkers associated with weight loss. Methods We studied 329 patients with morbid obesity undergoing three types of BS (biliopancreatic diversion (BPD), Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG)), depending on the %EWL one year after surgery: good responders (GR) (%EWL≥50%) and non-responders (NR) (%EWL <50%). Results The GR presented a higher percentage of change in anthropometric and biochemical variables compared to the NR group, even within each type of BS. There was a greater percentage of GR among those who underwent RYGB. The patients who underwent SG showed the lowest decrease in biochemical variables, both in GR and NR. Within the GR group, those with a lower age showed greater improvement compared to the other age groups. A %EWL ≥50% was negatively associated with the age and atherogenic index of plasma (AIP), and positively with the type of BS (RYGB). Conclusions The GR group was associated with lower age and AIP and undergoing RYGB. Additionally, those patients who underwent SG showed a lower metabolic improvement.

Keywords: bariatric surgery; excess weight loss; morbid obesity.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. World Health Organization Obesity and Overweight. [(accessed on 30 September 2020)];2017 Available online: .
    1. Sjöström L., Narbro K., Sjöström D., Karason K., Larsson B., Wedel H. Effects of bariatric surgery on mortality in swedish obese subjects. N. Engl. J. Med. 2007;357:741–752. doi: 10.1056/NEJMoa066254.
    1. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial-a prospective controlled intervention study of bariatric surgery. J. Intern. Med. 2013;273:219–234. doi: 10.1111/joim.12012.
    1. Still C.D., Wood G.C., Chu X., Manney C., Strodel W., Petrick A., Gabrielsen J., Mirshahi T., Argyropoulos G., Seiler J., et al. Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery. Obesity. 2014;22:888–894. doi: 10.1002/oby.20529.
    1. Camastra S., Muscelli E., Gastaldelli A., Holst J.J., Astiarraga B.D., Baldi S., Nannipieri M., Ciociaro D., Anselmino M., Mari A., et al. Long-Term Effects of Bariatric Surgery on Meal Disposal and β-Cell Function in Diabetic and Nondiabetic Patients. Diabetes. 2013;62:3709–3717. doi: 10.2337/db13-0321.
    1. MacLean L.D., Rhode B.M., Sampalis J., Forse R.A. Results of the surgical treatment of obesity. Am. J. Surg. 1993;165:155–162. doi: 10.1016/S0002-9610(05)80420-9.
    1. Maggard M.A., Shugarman L.R., Suttorp M., Maglione M., Sugerman H.J., Livingston E.H., Nguyen N.T., Li Z., Mojica W.A., Hilton L., et al. Meta-Analysis: Surgical Treatment of Obesity. Ann. Intern. Med. 2005;142:547. doi: 10.7326/0003-4819-142-7-200504050-00013.
    1. Sarzynski M., Jacobson P., Rankinen T., Carlsson B., Sjöström L., Bouchard C., Carlsson L.M.S. Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int. J. Obes. 2010;35:676–683. doi: 10.1038/ijo.2010.166.
    1. Sugerman H.J., Londrey G.L., Kellum J.M., Wolf L., Liszka T., Engle K.M., Birkenhauer R., Starkey J.V. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am. J. Surg. 1989;157:93–102. doi: 10.1016/0002-9610(89)90427-3.
    1. Stefanidis D., Kuwada T.S., Gersin K.S. The Importance of the Length of the Limbs for Gastric Bypass Patients—An Evidence-based Review. Obes. Surg. 2010;21:119–124. doi: 10.1007/s11695-010-0239-3.
    1. Nguyen N.T., Rivers R., Wolfe B.M. Factors associated with operative outcomes in laparoscopic gastric bypass. J. Am. Coll. Surg. 2003;197:548–555. doi: 10.1016/S1072-7515(03)00648-3.
    1. Melton G.B., Steele K.E., Schweitzer M.A., Lidor A.O., Magnuson T.H. Suboptimal Weight Loss after Gastric Bypass Surgery: Correlation of Demographics, Comorbidities, and Insurance Status with Outcomes. J. Gastrointest. Surg. 2007;12:250–255. doi: 10.1007/s11605-007-0427-1.
    1. Sans A., Bailly L., Anty R., Sielezenef I., Gugenheim J., Tran A., Gual P., Iannelli A. Baseline Anthropometric and Metabolic Parameters Correlate with Weight Loss in Women 1-Year After Laparoscopic Roux-En-Y Gastric Bypass. Obes. Surg. 2017;27:2940–2949. doi: 10.1007/s11695-017-2720-8.
    1. Campos G.M. Factors Associated With Weight Loss After Gastric Bypass. Arch. Surg. 2008;143:877–884. doi: 10.1001/archsurg.143.9.877.
    1. Coupaye M., Sabate J.M., Castel B., Jouët P., Clerici C., Msika S., LeDoux S. Predictive Factors of Weight Loss 1 Year after Laparoscopic Gastric Bypass in Obese Patients. Obes. Surg. 2010;20:1671–1677. doi: 10.1007/s11695-010-0159-2.
    1. Barhouch A.S., Padoin A.V., Casagrande D.S., Chatkin R., Süssenbach S.P., Pufal M.A., Rossoni C., Mottin C.C. Predictors of Excess Weight Loss in Obese Patients After Gastric Bypass: A 60-Month Follow-up. Obes. Surg. 2015;26:1178–1185. doi: 10.1007/s11695-015-1911-4.
    1. Ma Y., Pagoto S.L., Olendzki B.C., Hafner A.R., Perugini R.A., Mason R., Kelly J.J. Predictors of Weight Status following Laparoscopic Gastric Bypass. Obes. Surg. 2006;16:1227–1231. doi: 10.1381/096089206778392284.
    1. Contreras J.E., Santander C., Court I., Bravo J. Correlation Between Age and Weight Loss after Bariatric Surgery. Obes. Surg. 2013;23:1286–1289. doi: 10.1007/s11695-013-0905-3.
    1. Garrido-Sanchez L., Murri M., Rivas-Becerra J., Ocaña-Wilhelmi L., Cohen R., Garcia-Fuentes E., Tinahones F. Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy. Surg. Obes. Relat. Dis. 2012;8:145–150. doi: 10.1016/j.soard.2011.03.010.
    1. García-Fuentes E., Garrido-Sanchez L., Garcia-Almeida J.M., Garcia-Arnes J., Gallego-Perales J.L., Rivas-Marin J., Morcillo S., Cardona I., Soriguer F. Different Effect of Laparoscopic Roux-en-Y Gastric Bypass and Open Biliopancreatic Diversion of Scopinaro on Serum PYY and Ghrelin Levels. Obes. Surg. 2008;18:1424–1429. doi: 10.1007/s11695-008-9560-5.
    1. De Hollanda A., Ruiz T., Jiménez A., Flores L., Lacy A., Vidal J. Patterns of Weight Loss Response Following Gastric Bypass and Sleeve Gastrectomy. Obes. Surg. 2014;25:1177–1183. doi: 10.1007/s11695-014-1512-7.
    1. Reinhold R.B. Critical analysis of long term weight loss following gastric bypass. Surg. Gynecol. Obstet. 1982;155:385–394.
    1. Christou N.V., Look D., MacLean L.D. Weight Gain After Short- and Long-Limb Gastric Bypass in Patients Followed for Longer Than 10 Years. Ann. Surg. 2006;244:734–740. doi: 10.1097/01.sla.0000217592.04061.d5.
    1. Shen S.-W., Lu Y., Li F., Yang C.-J., Feng Y.-B., Li H.-W., Yao W.-F., Shen Z.-H. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 2018;17:1–6. doi: 10.1186/s12944-018-0656-1.
    1. Lemieux I., Lamarche B., Couillard C., Pascot A., Cantin B., Bergeron J., Dagenais G.R., Després J.-P. Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men. Arch. Intern. Med. 2001;161:2685–2692. doi: 10.1001/archinte.161.22.2685.
    1. Statements P. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(Suppl. 1):S11–S63.
    1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289:2560–2571. doi: 10.1001/jama.289.19.2560.
    1. Brethauer S.A., Kim J., Chaar M.E., Papasavas P., Eisenberg D., Rogers A. Standardized outcomes reporting in metabolic and bariatric surgery. Obes. Surg. 2015;25:587–606. doi: 10.1007/s11695-015-1645-3.
    1. Villarreal-Calderón J.R., Cuéllar R.X., Ramos-González M.R., Rubio-Infante N., Castillo E.C., Elizondo-Montemayor L. Interplay between the Adaptive Immune System and Insulin Resistance in Weight Loss Induced by Bariatric Surgery. Oxid. Med. Cell Longev. 2019;2019:3940739. doi: 10.1155/2019/3940739.
    1. Cottam D.R., Mattar S.G., Barinas-Mitchell E., Eid G., Kuller L., Kelley D.E., Schauer P.R. The Chronic Inflammatory Hypothesis for the Morbidity Associated with Morbid Obesity: Implications and Effects of Weight Loss. Obes. Surg. 2004;14:589–600. doi: 10.1381/096089204323093345.
    1. Leggio M., Lombardi M., Caldarone E., Severi P., D’Emidio S., Armeni M., Bravi V., Bendini M.G., Mazza A. The relationship between obesity and hypertension: An updated comprehensive overview on vicious twins. Hypertens. Res. 2017;40:947–963. doi: 10.1038/hr.2017.75.
    1. Park C.H., Korean Research Group for Endoscopic Management of Metabolic Disorder and Obesity. Nam S.-J., Choi H.S., Kim K.O., Kim D.H., Kim J.-W., Sohn W., Yoon J.H., Jung S.H., et al. Comparative Efficacy of Bariatric Surgery in the Treatment of Morbid Obesity and Diabetes Mellitus: A Systematic Review and Network Meta-Analysis. Obes. Surg. 2019;29:2180–2190. doi: 10.1007/s11695-019-03831-6.
    1. Liu F., He J., Wang H., Zhu D., Bi Y. Adipose Morphology: A Critical Factor in Regulation of Human Metabolic Diseases and Adipose Tissue Dysfunction. Obes. Surg. 2020:1–15. doi: 10.1007/s11695-020-04983-6.
    1. Garrido-Sánchez L., Tomé M., Santiago-Fernández C., García-Serrano S., García-Fuentes E., Tinahones F.J. Adipose tissue biomarkers involved in early resolution of type 2 diabetes after bariatric surgery. Surg. Obes. Relat. Dis. 2017;13:70–77. doi: 10.1016/j.soard.2016.03.010.
    1. Diamantis T., Apostolou K.G., Alexandrou A., Griniatsos J., Felekouras E., Tsigris C. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg. Obes. Relat. Dis. 2014;10:177–183. doi: 10.1016/j.soard.2013.11.007.
    1. Yu J., Zhou X., Li L., Li S., Tan J., Li Y., Sun X. The Long-Term Effects of Bariatric Surgery for Type 2 Diabetes: Systematic Review and Meta-analysis of Randomized and Non-randomized Evidence. Obes. Surg. 2014;25:143–158. doi: 10.1007/s11695-014-1460-2.
    1. Printen K.J., Mason E.E. Gastric bypass for morbid obesity in patients more than fifty years of age. Surg. Gynecol. Obstet. 1977;144:192–194.
    1. Livingston E.H., Huerta S., Arthur D., Lee S., De Shields S., Heber D. Male Gender is a Predictor of Morbidity and Age a Predictor of Mortality for Patients Undergoing Gastric Bypass Surgery. Ann. Surg. 2002;236:576–582. doi: 10.1097/00000658-200211000-00007.
    1. Dobiášová M. Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications. Clin. Chem. 2004;50:1113–1115. doi: 10.1373/clinchem.2004.033175.
    1. Murri M., García-Fuentes E., García-Almeida J.M., Garrido-Sanchez L., Mayas M.D., Bernal R., Tinahones F.J. Changes in Oxidative Stress and Insulin Resistance in Morbidly Obese Patients After Bariatric Surgery. Obes. Surg. 2009;20:363–368. doi: 10.1007/s11695-009-0021-6.
    1. Piché M.-È., Martin J., Cianflone K., Bastien M., Marceau S., Biron S., Hould F.-S., Poirier P. Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients. Metabolism. 2014;63:79–86. doi: 10.1016/j.metabol.2013.09.004.
    1. Perathoner A., Weißenbacher A., Sucher R., Laimer E., Pratschke J., Mittermair R. Significant Weight Loss and Rapid Resolution of Diabetes and Dyslipidemia During Short-Term Follow-Up After Laparoscopic Sleeve Gastrectomy. Obes. Surg. 2013;23:1966–1972. doi: 10.1007/s11695-013-1038-4.
    1. Khaitan L., Shea B.J. Laparoscopic vertical sleeve gastrectomy, long and short-term impact on weight loss and associated co-morbidities. Ann. Transl. Med. 2020;8:S5. doi: 10.21037/atm.2020.01.89.
    1. Bhandari M., Reddy M., Kosta S., Mathur W., Fobi M., Mohit B., Manoj R., Susmit K., Winni M., Mathias F. Laparoscopic sleeve gastrectomy versus laparoscopic gastric bypass: A retrospective cohort study. Int. J. Surg. 2019;67:47–53. doi: 10.1016/j.ijsu.2019.05.004.
    1. Osland E., Yunus R.M., Khan S., Memon B., Memon M.A. Weight Loss Outcomes in Laparoscopic Vertical Sleeve Gastrectomy (LVSG) Versus Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) Procedures. Surg. Laparosc. Endosc. Percutaneous Tech. 2017;27:8–18. doi: 10.1097/SLE.0000000000000374.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅